Skip to main content

Table 4 Patient demographics. Ranges and percentages are provided in parentheses.

From: Oral sildenafil (Viagra™) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital.

Mean age of patients in years

56.3 (18 – 85)

Race

 

   Caucasians

137

   Blacks

5

   Asians

5

Sexual orientation

 

   Heterosexuals

142

   Homosexuals

5

Mean duration of ED in years

4.7 (0.5 – 20)

Lack of libido

9 (6.1%)

Lack of nocturnal tumescence or early morning erections

43 (29.3%)

Reported frequency of sexual intercourse (per week) – mean

2.4 (0.25 – 10)

Aetiological groups

 

   Vasculogenic

39 (26.5%)

   Psychogenic

42 (28.6%)

   Neurogenic

4 (2.7%)

   Mixed

42 (28.6%)

   Diabetes

17 (11.6%)

   Hypogonadism

2 (1.4%)

   Drug induced

1 (0.7%)

Comorbidity

 

   Known diabetics

22 (15%)

   Known hypertension

27 (18.4%)

   Ischaemic heart disease (known angina / MI / treated for IHD)

15 (10.2%)

   Known arrythmia (with or without treatment)

8 (5.4%)

Peripheral vascular disease

15 (10.2%)

   Congestive heart failure

2 (1.4%)

   Low testosterone (proven on fasting sample; below normal or treated by GP with androgens for hypogonadism)

40 (31%, n = 129)

   Dyslipidemia (proven by blood test or on prophylactic statins)

18 (12.2%)

Alcohol consumption > 21 units per week

13 (8.8%)

Smokers

45 (30.6%)

Ex-smokers

65 (44.2%)

Non-smokers

37 (25.2%)